Lumos Pharma Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 2008
Revenue	2.05	1.52	0.23	0.17	0	12.47	28.71	35.77	68.5	172.59	Upgrade
Revenue Growth (YoY)	34.67%	562.17%	36.90%	-	-	-56.55%	-19.73%	-47.78%	-60.31%	15690.67%	Upgrade
Gross Profit	2.05	1.52	0.23	0.17	0	12.47	28.71	35.77	68.5	172.59	Upgrade
Selling, General & Admin	16.57	15.71	15.33	17.27	4.15	29.22	31.73	33.23	30.69	19.33	Upgrade
Research & Development	22.1	17.86	16.25	9.21	5.67	45.69	69.87	93.3	71.41	35.69	Upgrade
Operating Expenses	38.67	33.56	31.58	26.47	9.82	74.91	101.59	126.53	102.1	55.02	Upgrade
Operating Income	-36.61	-32.04	-31.35	-26.3	-9.82	-62.44	-72.88	-90.76	-33.6	117.57	Upgrade
Interest Expense / Income	0	0	0	0	0	0.05	0.12	0.02	0.11	0.03	Upgrade
Other Expense / Income	-2.55	-0.97	-0.28	-6.67	-0.11	-1.93	-0.49	-0.27	-0.06	-0.09	Upgrade
Pretax Income	-34.06	-31.08	-31.07	-19.64	-9.71	-60.56	-72.51	-90.51	-33.64	117.63	Upgrade
Income Tax	-0.03	-0.01	-0.64	-13.97	0	-6.97	-0.56	-5.36	6.74	21.62	Upgrade
Net Income	-34.03	-31.06	-30.43	-5.66	-9.71	-53.6	-71.95	-85.16	-40.38	96.02	Upgrade
Preferred Dividends	0	0	0	0.65	3.04	0	0	0	0	0	Upgrade
Net Income Common	-34.03	-31.06	-30.43	-6.31	-12.75	-53.6	-71.95	-85.16	-40.38	96.02	Upgrade
Shares Outstanding (Basic)	8	8	8	7	1	4	3	3	3	3	Upgrade
Shares Outstanding (Diluted)	8	8	8	7	1	4	3	3	3	3	Upgrade
Shares Change	-2.73%	0.47%	22.97%	420.42%	-68.48%	18.81%	8.02%	1.37%	-7.86%	22.75%	Upgrade
EPS (Basic)	-4.18	-3.71	-3.65	-0.93	-9.79	-12.96	-20.70	-26.46	-12.69	31.05	Upgrade
EPS (Diluted)	-4.18	-3.71	-3.65	-0.93	-9.79	-12.96	-20.70	-26.46	-12.69	27.81	Upgrade
Free Cash Flow	-31.1	-26.64	-29.68	9.47	-9.09	-37.82	-48.07	-68.19	-28.08	107.37	Upgrade
Free Cash Flow Per Share	-3.82	-3.18	-3.56	1.40	-6.98	-9.15	-13.82	-21.18	-8.84	34.71	Upgrade
Gross Margin	100.00%	100.00%	100.00%	100.00%	-	100.00%	100.00%	100.00%	100.00%	100.00%	Upgrade
Operating Margin	-1785.18%	-2103.74%	-13629.13%	-15656.55%	-	-500.55%	-253.84%	-253.74%	-49.05%	68.12%	Upgrade
Profit Margin	-1659.39%	-2039.53%	-13230.43%	-3758.33%	-	-429.65%	-250.60%	-238.08%	-58.95%	55.63%	Upgrade
Free Cash Flow Margin	-1516.09%	-1749.44%	-12903.48%	5638.69%	-	-303.21%	-167.43%	-190.65%	-41.00%	62.21%	Upgrade
Effective Tax Rate	-	-	-	-	-	-	-	-	-	18.38%	Upgrade
EBITDA	-34.02	-31.03	-30.85	-19.05	-9.67	-59.37	-70.98	-88.41	-31.95	118.76	Upgrade
EBITDA Margin	-1658.65%	-2037.16%	-13412.61%	-11340.48%	-	-475.92%	-247.24%	-247.16%	-46.64%	68.81%	Upgrade
Depreciation & Amortization	0.04	0.05	0.22	0.58	0.04	1.15	1.41	2.08	1.59	1.1	Upgrade
EBIT	-34.06	-31.08	-31.07	-19.64	-9.71	-60.51	-72.39	-90.49	-33.54	117.66	Upgrade
EBIT Margin	-1660.80%	-2040.38%	-13506.96%	-11688.10%	-	-485.10%	-252.14%	-252.99%	-48.96%	68.17%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).